Ulta Beauty, Inc. (ULTA) Guidance & Earnings Results

On 2026-08-27 Ulta Beauty, Inc. raised guidance: "FY26 net sales growth raised to 6.7-7.2% from 6-7%; comparable sales growth raised to 3.2-3.7% from 2.5-3.5%; operating income growth raised to 8.3-9.3% from 6.5-9%; diluted EPS raised to $28.70-$29.00 from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason

ULTAUlta Beauty, Inc.Follow ULTA — free

Specialty Retail · Consumer Cyclical

—

Price chart with a free account

Market cap: 26.7B
P/E TTM: 22.8
Dividend yield: —
52-week: —
Next earnings: 3 Dec, in 40 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
27 Aug 26	Raised	FY26 net sales growth raised to 6.7-7.2% from 6-7%; comparable sales growth raised to 3.2-3.7% from 2.5-3.5%; operating income growth raised to 8.3-9.3% from 6.5-9%; diluted EPS raised to $28.70-$29.00 from $28.36-$28.80; capex unchanged at $400M-$450M. · full year
2 Jun 26	Raised	EPS raised from $28.05-$28.55 to $28.36-$28.80 · full year
12 Mar 26	Raised	Net sales growth 6-7%, EPS $28.05-$28.55 · full year
4 Dec 25	Raised	Net sales ~$12.3B (prev $12.0-12.1B); comps 4.4-4.7% (prev 2.5-3.5%); op margin 12.3-12.4% (prev 11.9-12.0%); EPS $25.20-25.50 (prev $23.85-24.30) · full year
28 Aug 25	Reaffirmed	Updated fiscal 2025 outlook reflects strong H1 performance but caution on H2 consumer demand. · full year

Ulta Beauty, Inc. — questions

What guidance did Ulta Beauty, Inc. give?: On 2026-08-27: "FY26 net sales growth raised to 6.7-7.2% from 6-7%; comparable sales growth raised to 3.2-3.7% from 2.5-3.5%; operating income growth raised to 8.3-9.3% from 6.5-9%; diluted EPS raised to $28.70-$29.00 from $28.36-$28.80; capex unchanged at $400M-$450M."
When does Ulta Beauty, Inc. report earnings?: Ulta Beauty, Inc.'s next earnings report is expected on 2026-12-03.

Every figure on this page comes from Ulta Beauty, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.